Thais Sielecki-Dzurdz
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$7.0MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $7.0M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 21, 2021 | NIH | STTR Phase I Targeting the Integrated Stress Response effector ATF4 for mitigation of treatment-induced fibrosis | $336K | Veltion Therapeutics LLC with UNIVERSITY OF PENNSYLVANIA |
| Feb 10, 2020 | NIH | SBIR Phase II Optimization of LGM2605 for use as a device in lung transplant | $2.4M | Lignamed, LLC |
| Jul 25, 2019 | NIH | STTR Phase II IND enabling development of LGM2605 as adjuvant treatment for asthma | $3.0M | Lignamed, LLC with UNIVERSITY OF CALIFORNIA AT DAVIS |
| Aug 1, 2018 | NIH | STTR Phase I Graft-protective properties of LGM2605 in Lung Transplantation | $300K | Lignamed, LLC with UNIVERSITY OF PENNSYLVANIA |
| Jun 11, 2018 | NASA | SBIR Phase II LGM2605 as a Mitigator of Space Radiation-Induced Vascular Damage | $755K | Lignamed, LLC |
| Jul 18, 2017 | NIH | STTR Phase I Effects of LGM on a Primate Model of Asthma | $278K | Lignamed, LLC with UNIVERSITY OF CALIFORNIA AT DAVIS |
Peer ranks
Federal funding#142
Awards as PI#315
Patents#273
Companies
- Lignamed, LLCLinked by awards · Medtech
- Veltion Therapeutics LLCLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.